Your browser doesn't support javascript.
loading
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.
Dulucq, Stéphanie; Rigal-Huguet, Françoise; Nicolini, Franck E; Cony-Makhoul, Pascale; Escoffre-Barbe, Martine; Gardembas, Martine; Legros, Laurence; Rousselot, Philippe; Liu, Jixing; Rea, Delphine; De Mas, Véronique; Hayette, Sandrine; Raynaud, Sophie; Lacoste-Roussillon, Caroline; Robbesyn, Fanny; Klein, Emilie; Morisset, Stéphane; Mahon, François-Xavier; Etienne, Gabriel.
Afiliação
  • Dulucq S; Laboratory of Hematology, University Hospital of Bordeaux, Hôpital Haut Lévêque, Pessac, France.
  • Rigal-Huguet F; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Nicolini FE; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Cony-Makhoul P; Hematology Department, Institut Universitaire du Cancer, CHU de Toulouse, Toulouse, France.
  • Escoffre-Barbe M; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Gardembas M; INSERM U590, Centre de Recherche de Cancérologie de Lyon, Centre Léon Bérard, Lyon, France.
  • Legros L; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Rousselot P; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Liu J; Hematology Department, Centre Hospitalier Annecy-Genevois, Metz-Tessy, Pringy, France.
  • Rea D; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • De Mas V; Hematology Department, CHU de Pontchaillou, Rennes, France.
  • Hayette S; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Raynaud S; Hematology Department, CHU, Angers, France.
  • Lacoste-Roussillon C; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Robbesyn F; Hematology Department, AP-HP, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Klein E; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Morisset S; Hematology Department, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Mahon FX; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France.
  • Etienne G; Hematology & Oncology Department, Centre Hospitalier de Valence, Valence, France.
Br J Haematol ; 201(6): 1116-1124, 2023 06.
Article em En | MEDLINE | ID: mdl-37004981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article